Results 171 to 180 of about 2,454,151 (187)

CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder

Heliyon, 2021
Shuhei Nishiyama, Ichiro Nakashima, Kazuo Fujihara   +2 more
exaly  

Prevalence of neuromyelitis optica spectrum disorder in Belo Horizonte, Southeast Brazil

Multiple Sclerosis and Related Disorders, 2021
Marco Lana-Peixoto, Natalia C Talim, Jessica Marques Macedo   +2 more
exaly  

Sexual dysfunction in patients with neuromyelitis optica spectrum disorder

Journal of Neuroimmunology, 2020
Hongyu Zhou, Yuhan Qiu, Ziyan Shi
exaly  

Inebilizumab for treatment of neuromyelitis optica spectrum disorder in patients with prior rituximab use from the N-MOmentum Study

Multiple Sclerosis and Related Disorders, 2022
Bruce Cree, Maureen A Mealy, Eoin Flanagan   +2 more
exaly  

Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide

Frontiers in Neurology, 2020
Brian Weinshenker, Nasrin Asgari, Sean Pittock   +2 more
exaly  

The description of neuromyelitis optica spectrum disorder: Patient registry in Yangtze River Delta area of China

Multiple Sclerosis and Related Disorders, 2022
Chongbo Zhao, Jingzi Zhangbao, Wenjuan Huang   +2 more
exaly  

Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?

Multiple Sclerosis Journal, 2012
Woojun Kim, Su-Hyun Kim
exaly  

Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea

Multiple Sclerosis Journal, 2017
Byoung Joon Kim, Jong Kuk Kim, Ohyun Kwon   +2 more
exaly  

Clinical characteristics of 153 Brazilian patients with neuromyelitis optica spectrum disorder (NMOSD)

Multiple Sclerosis and Related Disorders, 2019
Benito Damasceno, Yara Dadalti Fragoso, Soniza Vieira Alves Leon   +2 more
exaly  

<p>Paraneoplastic neuromyelitis optica spectrum disorder associated with breast cancer</p>

Clinical Interventions in Aging, 2019
Wen-Li Hu, Wei Qin, Junliang Yuan
exaly